Halberd (Halberd) EBITDA Margin % : -14,866.67% (As of Jul. 2023)

View and export this data going back to 2009. Start your Free Trial

What is Halberd EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Halberd's EBITDA for the six months ended in Jul. 2023 was $-0.45 Mil. Halberd's Revenue for the six months ended in Jul. 2023 was $0.00 Mil. Therefore, Halberd's EBITDA margin for the quarter that ended in Jul. 2023 was -14,866.67%.

Halberd EBITDA Margin % Historical Data

The historical data trend for Halberd's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Halberd EBITDA Margin % Chart

Halberd Annual Data

Trend

Jul08

Jul22

Jul23

EBITDA Margin %

-500.00

-20,225.00

-14,866.67

Halberd Semi-Annual Data
	Jul08	Jul22	Jul23
EBITDA Margin %	-500.00	-20,225.00	-14,866.67

Competitive Comparison of Halberd's EBITDA Margin %

For the Biotechnology subindustry, Halberd's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Halberd's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Halberd's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Halberd's EBITDA Margin % falls into.

Halberd EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Halberd's EBITDA Margin % for the fiscal year that ended in Jul. 2023 is calculated as

EBITDA Margin %	=	EBITDA (A: Jul. 2023 )	/	Revenue (A: Jul. 2023 )
	=	-0.446	/	0.003
	=	-14,866.67 %

Halberd's EBITDA Margin % for the quarter that ended in Jul. 2023 is calculated as

EBITDA Margin %	=	EBITDA (Q: Jul. 2023 )	/	Revenue (Q: Jul. 2023 )
	=	-0.446	/	0.003
	=	-14,866.67 %

Halberd (OTCPK:HALB) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Halberd EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Halberd's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Halberd (Halberd) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Halberd Corp (OTCPK:HALB) » Definitions » EBITDA Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

P.O. Box 25, Jackson Center, PA, USA, 16133

Website

https://www.halberdcorporation.com

Halberd Corp is a research-based biotechnology company seeking to discover and develop medical treatments for a range of diseases. The Company's extracorporeal treatment is designed to treat hard-to-cure blood-borne, neurologic and infectious diseases. The Company's patented methodology removes the appropriate bodily fluid from the patient, in a continuous fashion, like dialysis, or in a batch process, like blood sample testing.

Executives

John Christopher Maddox	director, 10 percent owner, officer: President, COO, Treasurer and, other: Interim CFO	10755 VERNON, HUNTINGTON WOODS MI 48070
Mark Sven Lundquist	director, 10 percent owner, officer: CEO, Secretary and Director	24655 TUDOR LANE, FRANKLIN MI 48025
Cocco Nicholas A. Jr.	director	50104 N. JIMMY COURT, CHESTERFIELD MI 48047-1898
Leland Michael Thomas	director	280 LASALLE PLACE, GROSSE POINTE FARMS MI 88236